Overview
Key Metrics Quarterly
P&L
Balance Sheet
Cash Flows
Ratios
Shareholding
Documents
About
Zenith Healthcare Limited engages in the manufacturing and trading of pharmaceutical products in India and internationally. The company offers its products in the form of tablets, capsules, and liquids. It also provides contract manufacturing services of various dosage forms, including purchasing raw materials, production, packaging, and quality control. In addition, the company exports products in therapeutic segments, such as antibiotics and anti-infective, gastrointestinal, analgesic/anti-inflammatory, cardiovascular, respiratory, ophthalmology, bio-technical products, oncology, anti-retroviral, central nervous system, nutrition, genito urinary system, and skin. Further, it sells roadtep licenses products. Zenith Healthcare Limited was incorporated in 1994 and is based in Ahmedabad, India.
Key Metrics
as of Sep 2026
Market Cap 18 Cr
P/E 110.00
Div Yield 0.00 %
Book Value βΉ1.38
52w High βΉ4.98
52w Low βΉ2.23
Face Value βΉ1.00
Quarterly Results
Rs. Crores Β· hover row for definition
Metric
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Jun 2023
Sales
3.43
2.62
2.48
2.27
3.15
3.43
2.31
3.03
2.57
3.07
3.89
3.49
4.07
Expenses
3.26
3.08
2.20
2.10
3.29
3.41
2.51
2.89
2.45
3.31
3.79
3.36
3.76
Operating Profit
0.17
-0.46
0.28
0.17
-0.14
0.02
-0.20
0.14
0.12
-0.24
0.10
0.13
0.31
OPM %
4.96
-17.56
11.29
7.49
-4.44
0.58
-8.66
4.62
4.67
-7.82
2.57
3.72
7.62
Other Income
0.07
0.10
0.04
0.11
0.17
0.11
0.16
0.08
0.08
0.11
0.06
0.04
0.00
Depreciation
0.06
0.06
0.07
0.07
0.06
0.08
0.07
0.04
0.04
0.05
0.05
0.06
0.05
Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.00
0.00
Profit before tax
0.18
-0.42
0.25
0.21
-0.03
0.05
-0.11
0.18
0.16
-0.18
0.10
0.11
0.26
Tax %
22.22
-19.05
8.00
38.10
-33.33
-120.00
172.73
44.44
0.00
38.89
0.00
0.00
0.00
Net Profit
0.14
-0.34
0.22
0.14
-0.02
0.11
-0.29
0.09
0.16
-0.26
0.10
0.12
0.26
EPS in Rs
0.03
-0.06
0.04
0.03
0.00
0.02
-0.05
0.02
0.03
-0.05
0.02
0.02
0.05
Profit & Loss
Annual Β· Rs. Crores
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Sales
10.52 11.33 14.47 13.13 22.36 13.74 11.98 9.83 9.51 4.79 3.46 3.64
Expenses
10.65 11.24 14.23 13.10 21.91 13.38 11.43 9.63 8.95 4.73 3.69 3.68
Operating Profit
-0.13 0.09 0.24 0.03 0.45 0.36 0.55 0.20 0.56 0.06 -0.23 -0.04
OPM %
-1.24 0.79 1.66 0.23 2.01 2.62 4.59 2.03 5.89 1.25 -6.65 -1.10
Other Income
0.41 0.43 0.26 0.38 0.52 0.46 0.30 0.21 0.13 0.08 0.12 0.05
Interest
0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.01 0.01 0.01 0.01
Depreciation
0.26 0.23 0.21 0.28 0.36 0.25 0.25 0.25 0.28 0.30 0.35 0.35
Profit before tax
0.01 0.28 0.28 0.12 0.60 0.56 0.59 0.16 0.40 -0.17 -0.47 -0.35
Tax %
200.00 78.57 25.00 33.33 48.33 19.64 3.39 18.75 32.50 -11.76 -36.17 -31.43
Net Profit
0.01 0.07 0.20 0.08 0.31 0.44 0.57 0.14 0.27 -0.15 -0.31 -0.24
EPS in Rs
0.00 0.01 0.04 0.01 0.06 0.08 0.11 0.03 0.05 -0.03 -0.06 -0.04
Dividend Payout %
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Balance Sheet
Annual Β· Rs. Crores β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Equity Capital
5.37 5.37 5.37 5.37 5.37 5.37 5.37 5.37 5.37 5.37 5.37 5.37
Reserves
2.05 2.03 1.96 1.86 1.78 1.47 1.03 0.43 0.29 0.02 0.17 0.48
Borrowings
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.00 0.00 0.00 0.00
Other Liabilities
3.56 3.48 2.56 2.02 4.52 1.92 2.14 1.14 1.43 0.74 1.04 0.60
Total Liabilities
10.98 10.88 9.89 9.25 11.67 8.76 8.54 6.96 7.09 6.13 6.58 6.45
Fixed Assets
1.45 1.55 1.40 1.50 1.75 1.80 1.70 1.62 1.81 1.75 1.93 2.17
CWIP
0.00 0.00 0.00 0.00 0.00 0.00 0.17 0.00 0.00 0.00 0.00 0.00
Investments
0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Assets
9.52 9.33 8.49 7.75 9.92 6.96 6.67 5.34 5.28 4.38 4.65 4.28
Total Assets
10.98 10.88 9.89 9.25 11.67 8.76 8.54 6.96 7.09 6.13 6.58 6.45
Cash Flows
Annual Β· Rs. Crores β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Cash from Operating Activity
-0.83 0.55 1.74 -0.92 1.32 -1.47 1.95 -0.06 0.00 0.23 0.23 0.19
Cash from Investing Activity
0.85 -0.96 -1.88 -0.03 -0.23 -0.19 -0.50 -0.05 0.00 -0.12 0.01 -0.14
Cash from Financing Activity
-0.01 -0.01 0.00 0.00 0.00 0.00 -0.02 0.02 0.00 0.00 0.00 0.00
Net Cash Flow
0.01 -0.41 -0.14 -0.95 1.09 -1.65 1.44 -0.09 0.00 0.11 0.24 0.05
Free Cash Flow
-0.99 0.16 1.63 -0.95 1.08 -1.66 1.45 -0.11 0.00 0.11 0.11 -0.18
CFO/OP %
615.00 667.00 796.00 -2,967.00 333.00 -372.00 356.00 -15.00 0.00 383.00 -100.00 -475.00
Ratios
Annual Β· Days / % β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Debtor Days
72.51 77.96 57.26 64.22 53.05 44.89 31.08 33.79 54.88 84.58 132.92 183.50
Inventory Days
220.21 152.87 86.65 147.45 104.78 145.11 99.18 125.86 102.66 179.91 297.41 170.89
Days Payable
115.38 92.93 38.08 51.11 37.63 71.22 84.31 47.61 82.53 78.95 177.67 86.27
Cash Conversion Cycle
177.34 137.90 105.84 160.55 120.21 118.78 45.95 112.04 75.01 185.54 252.65 268.12
Working Capital Days
122.13 69.91 60.54 116.76 50.93 98.02 48.14 96.17 82.13 136.40 208.87 246.68
ROCE %
0.27 3.12 3.98 1.81 8.72 8.61 9.82 2.79 7.42 -2.93 -8.08 -5.71
Shareholding Pattern
% holding β latest first
Quarterly
Yearly
Holder
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Promoters
28.74
28.74
28.74
28.74
28.74
28.74
28.74
28.74
28.74
28.74
28.74
28.74
DIIs
0.39
0.39
0.39
0.39
0.39
0.39
0.39
0.39
0.39
0.39
0.39
0.39
Public
70.87
70.88
70.88
70.88
70.86
70.87
70.87
70.86
70.87
70.86
70.86
70.87
No. of Shareholders
38,725
39,077
39,693
40,454
41,137
41,284
39,959
36,491
33,886
33,879
33,326
33,147
Back to all stocks